Dose-response hyperplasia and neoplasia from feeding N-2-fluorenylacetamide (2-FAA) to BALB/c mice for varying time intervals.
Hyperplasia induced by N-2-fluorenylacetamide requires the continuous presence of the chemical for its maintenance. Feeding the chemical at levels of 8 to 86 ppm results in a dose-response related urinary bladder hyperplasia and, after 9 to 12 months, in bladder neoplasia at the higher dose levels. Neoplasia of the lungs, liver, parotid gland, lacrimal gland, harderian gland, and submaxillary gland was also observed. Measurement of oncogenic viruses revealed no synergism with 2-FAA and no relationship between virus counts and neoplasia. Calcareous pericarditis was observed and most general toxicological effects occurred in the liver. A pronounced sex difference in response was observed with the males giving greater responses than the females in all instances.
D015073:2-Acetylaminofluorene; D000818:Animals; D056486:Chemical and Drug Induced Liver Injury; D004305:Dose-Response Relationship, Drug; D005260:Female; D005449:Fluorenes; D006965:Hyperplasia / Q000139:chemically induced*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009374:Neoplasms, Experimental / Q000139:chemically induced; D012737:Sex Factors; D013997:Time Factors; D001745:Urinary Bladder Diseases / Q000139:chemically induced*; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced*
D005449:Fluorenes; D015073:2-Acetylaminofluorene